Comments on: Understanding the Pharmaceutical Market Access and Drug Safety Act of 2009 /edsblog/excerpts-from-pharmaceutical-market-access-and-drug-safety-act-of-2009/ Helping Americans get safe access to affordable medications. Mon, 06 May 2013 18:36:51 +0000 hourly 1 http://wordpress.org/?v=3.5.1 By: iGuide /edsblog/excerpts-from-pharmaceutical-market-access-and-drug-safety-act-of-2009/comment-page-1/#comment-206336 iGuide Sun, 06 Dec 2009 19:45:25 +0000 /edsblog/?p=1900#comment-206336 Ok, opening up the market to “tier 1″ countries is a start. But, they also overcharge to some lesser extent, probably for the same reasons we do. I have found quality drugs in other countries such as India, which has high quality standards. I purchased one drug in India which cost about USD $3, where the same drug would be USD $120 in the United States. Also, I purchased another quality drug which costs about USD $5 in New Zealand, and about USD $110 in the U.S. I have found topical antibiotics sold as cheaply as U.S. $0.20, which were effective. I should also mention that all of the drugs I’m talking about here were non-prescription in their respective countries, and are considered prescription-only in the U.S. Let’s also get rid of prescriptions for safe non-controlled substances in the U.S.

This kind of price difference is actually typical.

]]>